NCT03638258 - The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis | Biotech Hunter

Enrollment

331

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions

Plaque Psoriasis

Interventions

DRUG

Roflumilast Cream 0.3%

Applied once daily for 12 weeks

DRUG

Roflumilast Cream 0.15%

Applied once daily for 12 weeks

DRUG

Vehicle Cream

Applied once daily for 12 weeks

Trial Locations (30)

10029

Arcutis Clinical Site 22, New York

15213

Arcutis Clinical Site 15, Pittsburgh

23502

Arcutis Clinical Site 31, Norfolk

27262

Arcutis Clinical Site 14, High Point

32771

Arcutis Clinical Site 16, Sanford

33144

Arcutis Clinical Site 12, Miami

40217

Arcutis Clinical Site 21, Louisville

43209

Arcutis Clinical Site 39, Bexley

48038

Arcutis Clinical Site 34, Clinton Township

48202

Arcutis Clinical Site 33, Detroit

55432

Arcutis Clinical Site 20, Fridley

77004

Arcutis Clinical Site 37, Houston

77056

Arcutis Clinical Site 13, Houston

77598

Arcutis Clinical Site 24, Webster

77845

Arcutis Clinical Site 19, College Station

78213

Arcutis Clinical Site 23, San Antonio

90212

Arcutis Clinical Site 35, Beverly Hills

90403

Arcutis Clinical Site 27, Santa Monica

91324

Arcutis Clinical Site 29, Northridge

92123

Arcutis Clinical Site 28, San Diego

V3R 6A7

Arcutis Clinical Site 18, Surrey

V3V 0C6

Arcutis Clinical Site 11, Surrey

R3M 3Z4

Arcutis Clinical Site 38, Winnipeg

L1S 7K8

Arcutis Clinical Site 10, Ajax

N6H 5L5

Arcutis Clinical Site 25, London

L3P 1X2

Arcutis Clinical Site 26, Markham

L6J 7W5

Arcutis Clinical Site 32, Oakville

K9J 5K2

Arcutis Clinical Site 17, Peterborough

N2J 1C4

Arcutis Clinical Site 30, Waterloo

N8W 1E6

Arcutis Clinical Site 36, Windsor